Inferior pharyngeal constrictor electromyographic activity during permeability pulmonary edema in lambs.
Newborn mammals exhibit an active expiratory upper airway closure during the first hours of extrauterine life. We have recently shown that permeability pulmonary edema led to active expiratory glottic closure in awake newborn lambs while hypoxia (inspired O2 fraction 8%; 15 min) did not. In the present study, we tested the hypothesis that expiratory glottic closure was accompanied by an increase in pharyngeal constrictor muscle expiratory electromyographic (EMG) activity. We studied seven awake nonsedated lambs aged 8-20 days. Airflow (facial mask + pneumotachograph), blood gases (arterial catheter), and EMG activity of both the thyroarytenoid muscle (a glottic adductor) and the inferior pharyngeal constrictor muscle were recorded before and after intravenous injection of halothane (0.05 ml/kg) to induce a permeability pulmonary edema. A central apnea (duration 15 s to 5 min) with continuous thyroarytenoid and inferior pharyngeal constrictor activity was observed within seconds after halothane injection. One lamb died despite rescuing maneuvers. An expiratory phasic thyroarytenoid and inferior pharyngeal constrictor muscle activity with simultaneous zero airflow gradually took place and, by 30 min after halothane injection, was present at each expiration in the six remaining lambs. Expiratory glottic and pharyngeal constrictor muscle EMG activity was subsequently present during the whole study period (1.5-5 h), even after correction of the initial hypoxia. Permeability lung edema was present at postmortem examination in all seven lambs. We conclude that a permeability pulmonary edema induced by intravenous halothane in non-sedated lambs enhances both glottic and pharyngeal constrictor muscle expiratory EMG. We hypothesize that expiratory contraction of the inferior pharyngeal constrictor muscle could participate in the active expiratory upper airway closure; this, in turn, might improve alveolocapillary gas exchange by increasing the end-expiratory lung volume.
Department of Pediatrics, Faculty of Medicine, University of Sherbrooke, Quebec, Canada.
V
V
Diaz
I
I
Kianicka
P
P
Letourneau
J P
JP
Praud
D018681:Anesthetics, General / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001784:Blood Gas Analysis; D004576:Electromyography; D005931:Glottis / Q000503:physiopathology; D006221:Halothane / Q000494:pharmacology; D008176:Lung Volume Measurements; D009119:Muscle Contraction / Q000502:physiology; D009929:Organ Size / Q000502:physiology; D010539:Permeability; D010609:Pharyngeal Muscles / Q000503:physiopathology*; D011654:Pulmonary Edema / Q000503:physiopathology*; D015656:Respiratory Mechanics / Q000502:physiology; D012756:Sheep
D018681:Anesthetics, General; D006221:Halothane